129
Views
3
CrossRef citations to date
0
Altmetric
Original

PREDNOD, a prediction server for peptide binding to the H-2g7 haplotype of the non-obese diabetic mouse

, , , , &
Pages 645-650 | Received 06 Jun 2006, Accepted 01 Oct 2006, Published online: 07 Jul 2009

References

  • Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev 2005; 207: 145–157
  • Li P, Gregg JL, Wang N, Zhou D, O'Donnell P, Blum JS, Crotzer VL. Compartmentalization of class II antigen presentation: Contribution of cytoplasmic and endosomal processing. Immunol Rev 2005; 207: 206–217
  • Pamer E, Cresswell P. Mechanisms of MHC class I—restricted antigen processing. Annu Rev Immunol 1998; 16: 323–358
  • Villadangos JA, Bryant RA, Deussing J, Driessen C. Proteases involved in MHC class II antigen presentation. Immunol Rev 1999; 172: 109–120
  • Yewdell JW, Bennink JR. Cut and trim: Generating MHC class I peptide ligands. Curr Opin Immunol 2001; 13: 13–18
  • Bryant P, Ploegh H. Class II MHC peptide loading by the professionals. Curr Opin Immunol 2004; 16: 96–102
  • Zhong W, Reche PA, Lai CC, Reinhold B, Reinherz EL. Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire. J Biol Chem 2003; 278: 45135–45144
  • Brusic V, Zeleznikow J. Computational binding assays of antigenic peptides. Lett Pept Sci 1999; 6: 313–324
  • Brusic V, Bajic VB, Petrovsky N. Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications. Methods 2004; 34: 436–443
  • De Groot AS, Saint-Aubin C, Bosma A, Sbai H, Rayner J, Martin W. Rapid determination of HLA B*07 ligands from the west nile virus NY99 genome. Emerg Infect Dis 2001; 7: 706–713
  • Alyanakian MA, You S, Damotte D, Gouarin C, Esling A, Garcia C, Havouis S, Chatenoud L, Bach JF. Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases. Proc Natl Acad Sci USA 2003; 100: 15806–15811
  • Aoki CA, Borchers AT, Ridgway WM, Keen CL, Ansari AA, Gershwin ME. Autoimmun Rev 2005; 4: 373–379
  • Aly T, Devendra D, Eisenbarth GS. Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes. Am J Ther 2005; 12: 481–490
  • Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85: 291–297
  • Stratmann T, Apostolopoulos V, Mallet-Designe V, Corper AL, Scott CA, Wilson IA, Kang AS, Teyton L. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. Immunology 2000; 165: 3214–3225
  • Rammensee HG, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 1999; 50: 213–219
  • Reche PA, Glutting JP, Reinherz EL. Prediction of MHC class I binding peptides using profile motifs. Hum Immunol 2002; 63: 701–709
  • Udaka K, Wiesmuller K, Kienle S, Jung G, Takamura H, Yamagishi H, Okumura K, Walden P, Suto T, Kawasaki T. An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 2000; 51: 816–828
  • Zhang G, Srinivasan KN, Veeramani A, August T, Brusic V. PREDBALB/C: A system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse. Nucleic Acids Res 2005; 33: W180–W183
  • Reich EP, von Grafenstein H, Barlow A, Swenson KE, Williams K, Janeway CA. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J Immunol 1994; 152: 2279–2288
  • Amor S, O'Neill JK, Morris MM, Smith RM, Wraith DC, Groome N, Travers PJ, Baker D. Encephalitogenic epitopes of myelin basic protein, proteolipid proteing, and myelin oligodendrocyte glycoprotein for experimental allergic en-cephalomyelitis induction in Biozzi AB/H(H-2Ag7) mice share an amino acid motif. Immunology 1996; 156: 3000–3008
  • Reizis B, Eisenstein M, Bockova J, Konene-Waisman S, Mor F, Elias D, Cohen IR. Molecular characterization of the diabetes mouse MHC class-II protein, I-Ag7. Int Immunol 1997; 9: 43–51
  • Harrison LC, Honeyman MC, Trembleau S, Gregori S, Gallazzi F, Augestein P, Brusic V, Hammer J, Adorini L. A peptide binding motif for I-Ag7, the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice. J Exp Med 1997; 185: 1013–1021
  • Latek RR, Suri A, Petzold SJ, Nelson CA, Kanagawa O, Unanue ER, Fremont DH. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 2000; 12: 699–710
  • Corper AL, Stratmann T, Apostolopoulos V, Scott CA, Garcia KC, Kang AS, Wilson IA, Tevton L. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 2000; 288: 505–511
  • Gregori S, Bono E, Gallazzi F, Hammer J, Harrison LC, Adorini L. The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library. Int Immunol 2000; 12: 493–503
  • Rajapakse M, Wyse L, Schmidt B, Brusic V. Deriving matrix of peptide interactions in diabetic mouse by genetic algorithm. Lect Notes Comp Sci 2005; 3578: 440–447
  • Swets JA. Measuring the accuracy of diagnostic systems. Science 1998; 240: 1285–1293
  • Yu B, et al. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes. J Immunol 2000; 30: 2497–2506
  • Brusic V, Rudy G, Harrison LC. MHCPEP, a database of MHC-binding peptides. Nucleic Acids Res 1994; 22: 3663–3665
  • Bhasin M, Singh H, Raghava GP. MHCBN: A comprehensive database of MHC binding and non-binding peptides. Bioinformatics 2003; 19: 665–666
  • McSparron H, Blythe MJ, Zygouri C, Doytchinova IA, Flower DR. JenPep: A novel computational information resource for immunobiology and vaccinology. J Chem Inf Comput Sci 2004; 43: 1276–1287
  • Rammensee HG, Falk K, Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993; 11: 213–244
  • Yu K, Petrovsky N, Schönbach C, Koh JYL, Brusic V. Methods for prediction of peptide binding to MHC molecules: A comparative study. Mol Med 2002; 8: 137–148
  • Quesnel A, Hsu SC, Delmas A, Steward MW, Trudelle Y, Abastado JP. Efficient binding to the MHC class I K(d) molecule of synthetic peptides in which the anchoring position 2 does not fit the consensus motif. FEBS Lett 1996; 387: 42–46
  • Sette A, Buus S, Appella E, Smith JA, Chesnut R, Miles C, Colon SM, Grey HM. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci USA 1989; 86: 3296–3300
  • Mata M, Travers PJ, Liu Q, Frankel FR, Paterson Y. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D1. J Immunol 1998; 161: 2985–2993
  • Saikh KU, Martin JD, Nishikawa AH, Dillon SB. Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72. Virology 1995; 214: 445–452
  • Zatechka DS, Jr, Hegde NR, Hariharan K, Srikumaran S. Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1. Vaccine 1999; 17: 686–694
  • Pe'er I, et al. Proteomic signatures: Amino acid and oligopeptide compositions differentiate among phyla. Proteins 2004; 54: 20–40
  • Reche PA, Glutting JP, Reinherz EL. Prediction of MHC class I binding peptides using profile motifs. Hum Immunol 2002; 63: 701–709
  • Reche PA, Zhang H, Glutting JP, Reinherz EL. EPIMHC: A curated database of MHC-binding peptides for customized computational vaccinology. Bioinformatics 2005; 21: 2140–2141
  • Lyman M, Lee H, Kang B, Kang H, Kim B. Capsid-specific cytotoxic T lymphocytes recognize three distinct H-2D(b)-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles. J Virol 2002; 76: 3125–3134
  • Saren A, Pascolo S, Stevanovic S, et al. Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes. Infect Immun 2002; 70: 3336–3343
  • Sigal L, Goebel P, Wylie D. Db-binding peptides from influenza virus: Effect of non-anchor residues on stability and immunodominance. Mol Immunol 1995; 32: 623–632
  • Hudrisier D, Mazarguil H, Laval F, Oldstone M, Gairin J. Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues: Implications for peptide selection and presentation. J Biol Chem 1996; 271: 17829–17836
  • Blythe MJ, Doytchinova IA, Flower DR. JenPep: A database of quantitative functional peptide data for immunology. Bioinformatics 2002; 18: 434–439
  • Gupta V, Tabiin TM, Sun K, Chandrasekaran A, Anwar A, Yang K, Chikhlikar P, Salmon J, Brusic V, Marques ET, Kellathur SN, August TJ. SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens. Virology 2006; 347: 27–39
  • Suri A, Walters JJ, Levisetti MG, Gross ML, Unanue ER. Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells. Eur J Immunol 2006; 36(3)544–557
  • Suri A, et al. In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket. J Immunol 2002; 168: 1235–1243

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.